$HTGC

Hercules Capital, Inc.

No enriched coverage for $HTGC in the last 7 days.

No SEC Form 4 filings for $HTGC in the last 30 days.

Med

Hercules Capital (NYSE:HTGC) Posts Earnings Results, Misses Expectations By $0.24 EPS

Hercules Capital (NYSE:HTGC) reported Q1 EPS of $0.48, beating analyst estimates by $0.01, but missed revenue expectations with $134.94 million against an estimated $141.39 million. The company achieved record new commitments of $1.81 billion and has seen increased leverage and several analyst rating changes, including price target adjustments and a downgrade to "hold" by Weiss Ratings. Despite some negative sentiment regarding legal risks from a Hunterbrook report and Q1 revenue miss, the consensus rating remains "Moderate Buy" with an average price target of $18.04.

HTGC Shareholder Alert: Hercules Capital, Inc. Securities Class Action Lawsuit - Investors Should Contact The Gross Law Firm

The Gross Law Firm has issued a shareholder alert for Hercules Capital, Inc. (NYSE: HTGC) concerning a securities class action lawsuit. The lawsuit alleges that Hercules Capital made materially false and/or misleading statements regarding its due diligence, portfolio valuation processes, and misclassified portfolio investments. The firm encourages shareholders who purchased HTGC shares between May 1, 2025, and February 27, 2026, to contact them before the May 19, 2026 deadline to register for the class action.

Senseonics says cash can fund operations into 2028 after loan expansion

Senseonics Holdings, Inc. has expanded its loan agreement with Hercules Capital, increasing its borrowing capacity from $100 million to $140 million. This amendment, combined with recent equity proceeds and existing cash, is expected to fund the company's operations into 2028. The additional funding will support the development of its Freedom product, ongoing commercialization of Eversense 365, and upcoming pivotal trials.